F2G raises $100M to advance olorofim after FDA rejection
Infections caused by Aspergillus species of mold are transmitted through inhalation and can lead to symptoms including hypersensitivity reactions and tissue damage. Invasive aspergillosis (IA)...
German pharma to submit FDA application after nerandomilast success
Boehringer Ingelheim reported this week that its phase 3 Fibroneer-IPF trial had met its primary endpoint of an improvement in Forced Vital Capacity (FVC), a...
CluePoints unveils expert speaker line-up for RBQMLive 2024
As the premier sponsor, CluePoints is helping to elevate RBQMLive as the industry’s leading event focused on the evolving field of risk-based quality management. Taking...
Women in Science – Vaxess CEO on owning your seat at the table
She is CEO of Vaxess and wants to be able to deliver therapeutics in the most patient-friendly and pain-free way. Read our interview with her...
EORTC extends Medidata partnership to advance data-driven cancer research
The four-year extension focuses heavily on enhancing data management in oncology research, allowing EORTC to streamline patient access to clinical trials and optimize trial participation...
Slope unveils tech-enabled solutions to optimize clinical trial data
The company’s latest offering empowers clinical trial sponsors to harness the full potential of their biospecimen data, transforming it into actionable insights throughout the trial...
Envision Pharma Group unveils new data management platform
The company says this new data and analytics management solution marks a significant shift in how medical affairs professionals can access, manage, and optimize complex...
Optimize clinical trials with Phastar’s RBQM app & analytics
The tool supports critical RBQM processes like risk assessment, central monitoring, issue management, risk reassessment, targeted site monitoring, and KRI tracking, while ensuring regulatory compliance...
ethics and AI in healthcare marketing
Leslie Pascaud, chief marketing officer at ObvioHealth, believes the key to effective marketing remains grounded in three fundamentals: a compelling product, addressing genuine customer needs,...
AI and a growing confidence in transforming drug development
In this Q&A, Dr Fabrice Chartier (FC), CEO of Simbec-Orion and Joern Klinger (JK), CEO of biotx.ai explore AI-enabled causal modeling, its unique advantages and...
Remote dosing and culturally informed OUD solutions
The report, called ‘The strategic allocation of opioid settlement funds – an evidence-based approach to preventing deaths from opioid use disorder’ examines both the challenges...
The need for new clinical trial designs in cancer
Ravi Karra, VP of Oncology at the service provider Advanced Clinical, explains how advanced imaging techniques and trial designs can overcome the obstacles of taking...
Women in Science – Cytiva’s Emannuelle Cameau
Read our interview to discover how losing her beloved horse ended her desire to be a vet to her belief in destiny and transformative power...
AI-enabled platform by Creyon Bio receives second US Patent
This patent protects the company’s proprietary Creyon platform, which rapidly engineers and optimizes OBMs, marking a significant advancement in the field of precision medicine. The...
New report investigates pharma’s global reach and impact
A new report from the Access to Medicine Foundation takes a groundbreaking look at how some of the largest pharmaceutical companies are addressing patient access...
Women in Science – Cytiva’s Beate Mueller
With a passion for science and an ‘eternal technology optimist’, she says playing a role in getting patients they need is humbling and motivating. Find...
Seqster, PatientsLikeMe join forces to enhance clinical research
This collaboration, the healthcare technology companies say, promises to streamline clinical trial recruitment and optimize long-term patient engagement. “This partnership unlocks enormous value for patients,...
LabWare and Mettler Toledo integrate software for lab efficiency
The connector seamlessly integrates LabWare’s Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN) with Mettler Toledo’s LabX software, providing a streamlined solution for...
How SOMS is shaping the future of clinical trials
Kizewski delves into how SOMS is changing trial design, optimizing patient safety, and enhancing the chances of FDA approval, providing critical insights into the future...
Blood-based Alzheimer’s test set to revolutionize early diagnosis
The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and less invasive. The introduction of a blood-based...
